@article{661ce76bf086402dac6c8377a88b5318,
title = "The moderating effect of age on the associations of cognitive and metacognitive beliefs with pediatric OCD symptoms",
abstract = "Although considerable research has highlighted the importance of cognitive and metacognitive beliefs in adult obsessive-compulsive disorder (OCD), there has been limited investigation of these beliefs in pediatric OCD. The present study investigated the clinical correlates of cognitive and metacognitive beliefs in pediatric OCD. Previous studies found positive relations between OCD symptoms and these beliefs in pediatric patients, and we hypothesized these beliefs would also be positively related to pediatric OCD symptom severity. We additionally hypothesized age would moderate these relationships in consideration of previous studies highlighting age differences in symptom presentation and self-reported beliefs. We also explored age differences in belief endorsements. Youth aged 7–17 (n = 142) diagnosed with OCD completed self-report scales to measure cognitive and meta-cognitive beliefs. OCD severity was assessed using self-report and clinician-rated measures. Pearson correlations, moderation analyses, and independent-samples t-tests were used to test our hypotheses and aims. Significant positive relationships were observed between cognitive and metacognitive beliefs and self-reported OCD severity, although age did not moderate these relationships. Age differences were found in belief endorsements. In conclusion, cognitive and metacognitive beliefs appear clinically relevant to pediatric OCD cases, and we recommend clinicians assess these beliefs and incorporate cognitive components to corresponding evidence-based treatment.",
keywords = "Cognitive beliefs, age, disorder, metacognitive beliefs, moderation, pediatric obsessive-compulsive",
author = "Myles Rizvi and Hannah Smilansky and Rachel Porth and Nicholas Myers and Daniel Geller and Small, {Brent J.} and McGuire, {Joseph F.} and Sabine Wilhelm and Storch, {Eric A.}",
note = "Funding Information: Dr. Storch receives research support from NIH, Agency for Healthcare Research and Quality, International OCD Foundation, and All Children{\textquoteright}s Hospital Research Foundation. Dr. Storch is on the Speaker{\textquoteright}s Bureau and Scientific Advisory Board for the International OCD Foundation. Funding Information: Dr. Geller reports grant support from NIH and book honorarium from the American Academy of Child and Adolescent Psychiatry, speaking honoraria for Advanced Institute lectures from the American Academy of Child and Adolescent Psychiatry and Massachusetts General Hospital Psychiatry Academy in educational programs supported through independent medical education grants from pharmaceutical companies. Lifetime funding includes support from the Obsessive Compulsive Disorder Foundation, The Tourette Syndrome Association, The McIngvale Family Foundation, Eli Lilly, Pfizer, and Glaxo Smith Kline. Funding Information: Dr. McGuire receives grant funding from the Tourette Association of America and National Institutes of Health. Funding Information: This work was supported by grants from the National Institute of Mental Health (NIMH) to Drs. Storch (1R01MH093381) and Geller (5R01MH093402). Role of the Sponsor: The funding organization was not involved in the design or conduct of the study; collection, management, analysis, and interpretation of the data or preparation, review, and approval of the manuscript. Opinions expressed in this article reflect those of the authors and are not necessarily reflective of those of the National Institute of Mental Health. Publisher Copyright: {\textcopyright} 2020 Swedish Association for Behaviour Therapy.",
year = "2021",
doi = "10.1080/16506073.2020.1819866",
language = "English (US)",
volume = "50",
pages = "104--120",
journal = "Cognitive Behaviour Therapy",
issn = "1650-6073",
publisher = "Taylor and Francis AS",
number = "2",
}